Simeng Hu
Impact in
- Dermatology top 5%
- Cutaneous lymphoproliferative disorders research
Papers in
-
- Cutaneous lymphoproliferative disorders research 3
- Oncology 3
- Cancer Immunotherapy and Biomarkers 2
- Cancer Cells and Metastasis 1
- Co-authors
- Fan Bai (4 shared papers)Xudong Xing (2 shared papers)Dikan Wang (1 shared paper)Wei Dong (1 shared paper)Wenxiao Dai (1 shared paper)Huanzi Lu (1 shared paper)Zhi Wang (1 shared paper)Juan Fang (1 shared paper)
- Journals
- Nature Communications (2 papers)Journal of Clinical Investigation (1 paper)European Heart Journal (1 paper)Frontiers in Neuroscience (1 paper)JCI Insight (1 paper)
- Partner nations
- ChinaUnited KingdomItaly
In The Last Decade
Simeng Hu
14 papers receiving 300 citations
Peers
Comparison fields: 5 of 49
- Dermatology 64
- Biological Psychiatry 5
- Oncology 59
- Otorhinolaryngology 13
- Immunology 32
Countries citing papers authored by Simeng Hu
This map shows the geographic impact of Simeng Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simeng Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simeng Hu more than expected).
Fields of papers citing papers by Simeng Hu
This network shows the impact of papers produced by Simeng Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simeng Hu. The network helps show where Simeng Hu may publish in the future.
Co-authors
The 25 scholars most cited alongside Simeng Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 76 | |
| 2 | 2022 | 65 | |
| 3 | 2018 | 33 | |
| 4 | 2023 | 26 | |
| 5 | 2024 | 23 | |
| 6 | 2018 | 21 | |
| 7 | 2024 | 20 | |
| 8 | 2022 | 15 | |
| 9 | 2024 | 10 | |
| 10 | 2019 | 7 | |
| 11 | 2017 | 3 | |
| 12 | Management of functional, hepatic damage after chemotherapy with Liverubin (pharma-standard silymarin). | 2015 | 1 |
| 13 | 2017 | 1 | |
| 14 | 2017 | 1 |
About Simeng Hu
Simeng Hu is a scholar working on Dermatology, Oncology, Virology, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 14 papers that have together received 302 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (3 papers), Cutaneous lymphoproliferative disorders research (3 papers), Cancer Immunotherapy and Biomarkers (2 papers), Rabies epidemiology and control (1 paper), Cancer Cells and Metastasis (1 paper), Carcinogens and Genotoxicity Assessment (1 paper), Radiation Dose and Imaging (1 paper) and Silymarin and Mushroom Poisoning (1 paper). The work is most often cited by research in Dermatology (64 citations), Biological Psychiatry (5 citations), Oncology (59 citations), Otorhinolaryngology (13 citations) and Immunology (32 citations). Simeng Hu has collaborated with scholars based in China, United Kingdom and Italy. Frequent co-authors include Fan Bai, Xudong Xing, Dikan Wang, Wei Dong, Wenxiao Dai, Huanzi Lu, Zhi Wang, Juan Fang, Shuqiong Wen and Qianming Chen. Their work appears in journals such as Nature Communications, Journal of Clinical Investigation, European Heart Journal, Frontiers in Neuroscience and JCI Insight.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.